An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes

Inclusion Criteria: * Male or female * ≥ 18 years old * Has been already diagnosed with hypertension * Has been already diagnosed with type 2 diabetes mellitus * Started using angiotensin-converting enzyme inhibitor and non-dihydropyridine calcium channel blocker single pill combination within a maximum of 1 week before enrolment * Heart rate ≥70 beat per minute Exclusion Criteria: * Pregnant or breast feeding female * Current need to use any other antihypertensive drug(s) in addition to angiotensin-converting enzyme inhibitor and non-dihydropyridine calcium channel blocker single pill combination * Having any contraindication for angiotensin-converting enzyme inhibitor or non-dihydropyridine calcium channel blocker; * Has been treated by any anti-hypertensive treatment(s) before angiotensin-converting enzyme inhibitor and non-dihydropyridine calcium channel blocker single pill combination * Is currently participating in another clinical or non-clinical study